Navigation Links
Synteract Sponsoring and Presenting at Outsourcing in Clinical Trials Southeast Conference
Date:5/8/2012

SAN DIEGO and RALEIGH-DURHAM, N.C., May 8, 2012 /PRNewswire/ -- Synteract, Inc., a full-service contract research organization (CRO), will be a corporate sponsor and have two senior level directors from its Research Triangle Park office speak at the inaugural Outsourcing in Clinical Trials Southeast conference to be held at the Durham Marriott Convention Center, May 15-16, 2012. Barbara Conley, associate director of clinical operations, and Matt Anders, associate director of project management, will co-present at 10:30 a.m. EDT, Wed., May 16th, on how to identify viable investigative sites that contribute to the success of a company's clinical study.

(Logo: http://photos.prnewswire.com/prnh/20111108/MM02925LOGO

The conference series is nationally respected and attended by vendors and sponsors in the pharmaceutical and biotech industries. Conley and Ander's presentation will address one of the growing concerns within drug development; how to find and choose viable trial sites.

Topics will include: 

  • Identifying what makes a site feasible for your trial
  • Establishing whether a site has ongoing studies competing for the same patient population
  • Assessing whether the site meets the country's standard of care  
  • Forecasting whether the length of your trial is acceptable to investigational staff and patients
  • Evaluating the availability of specialized equipment and expertise
  • Analyzing the consistency of the investigator budget with the level of investigational site effort required

According to Synteract executives, with trial costs on the rise finding appropriate investigative sites is a key driver in efficient trial conduct.  With site selection a critical component in the overall drug development process, it is important for biopharma companies of all sizes to work with a CRO that can facilitate choosing viable trial sites.

"After nearly two decades of operations, we're known for having a unique understanding of emerging pharma and biotech, particularly on the West Coast, where we are headquartered," stated Stewart Bieler, chief operating officer. "We continue to enhance the breadth and depth of our Raleigh-based service offering in response to increasing East Coast-based client demand.  This allows us to continue to offer a level of individualized service from experienced clinical development professionals on each project."

Synteract will exhibit at booth #27. CEO Wendel Barr will be available to discuss the company's Shared Work-Shared Vision approach where every project and client receives collaborative, customized service that is tailored to their needs. To set up an appointment in advance, contact Michele Sacher, associate business development director, at 484.467.5937 or msacher@synteract.com

About Synteract (www.synteract.com)
Synteract is a full-service contract research organization with a successful 17-year track record supporting biotechnology, medical device and pharmaceutical companies in all phases of clinical development.  With its "Shared Work – Shared Vision" philosophy Synteract provides customized Phase I through IV services collaboratively and cost effectively to ensure on-time delivery of quality data so clients get to decision points faster. Headquartered in California, with offices in North Carolina and the Czech Republic, Synteract delivers trials internationally, offering expertise across multiple therapeutic areas including notable depth in oncology, CNS, cardiovascular, respiratory and ophthalmology. 

CONTACT:
Rachel Hutman
Clearpoint Agency, for Synteract
rachel@clearpointagency.com
+1-760-230-2424


'/>"/>
SOURCE Synteract, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Synteract and Rempex Partner in "Great Strides" Walk to Support Cystic Fibrosis Cure
2. Synteract Expands Executive Roles to Support Growth
3. Synteract Hosting CDISC Classes on Regulatory Data Standards, Feb. 21-24, in California
4. Former Synteract CEO Unveils Non-Profit Contract Research Organization, PHACT, to Help Eliminate Neglected Diseases in Developing Countries
5. Synteract Releases SynCapture Version 1.5 of Its Hybrid Electronic Data Capture (EDC) System
6. RxAlly Expands National Network With Addition Of Nineteen Community Pharmacy Organizations Representing Over 2,000 Pharmacies
7. Attorney Mark Lanier Presenting Keynote at National Mesh Litigation Conference
8. Parata Systems Announces Presenting Sponsorship of 2012 Independent Pharmacy Business Growth Conference
9. Genprex Presenting at 10th Annual BIO Investor Forum
10. AMD Alliance, Representing AMD Patient Organizations Globally, Encourages Health Care Providers to Stop Using Avastin for Off-Label Ocular Use
11. Investment in Oncology Drug Development Remains Strong as 133 Companies Initiate Late-Stage Clinical Trials Representing a 21% Increase
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... 24, 2016  Global Blood Therapeutics, Inc. (GBT) (NASDAQ: ... novel therapeutics for the treatment of grievous blood-based ... closing of its previously announced underwritten public offering ... public offering price of $18.75 per share. All ... by GBT. GBT estimates net proceeds from the ...
(Date:6/24/2016)... DUBLIN , June 24, 2016 ... and Markets has announced the addition of the ... their offering. ... products and provides an updated review, including its applications ... covering the total market, which includes three main industries: ...
(Date:6/24/2016)... 2016 The Academy of Managed Care Pharmacy ... that would allow biopharmaceutical companies to more easily share ... formulary and coverage decisions, a move that addresses the ... The recommendations address restrictions in the sharing ... drug label, a prohibition that hinders decision makers from ...
Breaking Medicine Technology:
(Date:6/27/2016)... ... , ... TopConsumerReviews.com recently awarded their highest five-star rating to Best Buy Eyeglasses, ... the United States and Canada wear eyeglasses. Once considered to be a purely functional ... a fashion statement. Even celebrities use glasses as a way of creating an iconic ...
(Date:6/26/2016)... , ... June 26, 2016 , ... Pixel Film Studios ... X. , "Film editors can give their videos a whole new perspective by using ... - CEO of Pixel Film Studios. , ProSlice Levels contains over 30 Different ...
(Date:6/26/2016)... ... June 26, 2016 , ... Many women ... diagnosed with endometriosis. These women need a treatment plan to not only alleviate ... that can help for preservation of fertility and ultimately achieving a pregnancy. The ...
(Date:6/25/2016)... , ... June 25, 2016 , ... The temporary closing of Bruton Memorial Library on ... Observer , brings up a new, often overlooked aspect of head lice: the parasite’s ability ... fumigation is not a common occurrence, but a necessary one in the event that lice ...
(Date:6/25/2016)... ... , ... As a lifelong Southern Californian, Dr. Omkar Marathe earned his Bachelors ... Geffen School of Medicine at UCLA. He trained in Internal Medicine at Scripps Green ... hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the opportunity to train ...
Breaking Medicine News(10 mins):